472 related articles for article (PubMed ID: 15054110)
21. Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer.
Landen CN; Lu C; Han LY; Coffman KT; Bruckheimer E; Halder J; Mangala LS; Merritt WM; Lin YG; Gao C; Schmandt R; Kamat AA; Li Y; Thaker P; Gershenson DM; Parikh NU; Gallick GE; Kinch MS; Sood AK
J Natl Cancer Inst; 2006 Nov; 98(21):1558-70. PubMed ID: 17077358
[TBL] [Abstract][Full Text] [Related]
22. Hypoxia-induced mitogenic factor enhances angiogenesis by promoting proliferation and migration of endothelial cells.
Tong Q; Zheng L; Li B; Wang D; Huang C; Matuschak GM; Li D
Exp Cell Res; 2006 Nov; 312(18):3559-69. PubMed ID: 16982054
[TBL] [Abstract][Full Text] [Related]
23. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
Stalmans I
Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of EphA2 during in vivo and in vitro renal ischemia-reperfusion injury: role of Src kinases.
Baldwin C; Chen ZW; Bedirian A; Yokota N; Nasr SH; Rabb H; Lemay S
Am J Physiol Renal Physiol; 2006 Nov; 291(5):F960-71. PubMed ID: 16735461
[TBL] [Abstract][Full Text] [Related]
25. Activated protein C induces endothelial cell proliferation by mitogen-activated protein kinase activation in vitro and angiogenesis in vivo.
Uchiba M; Okajima K; Oike Y; Ito Y; Fukudome K; Isobe H; Suda T
Circ Res; 2004 Jul; 95(1):34-41. PubMed ID: 15166095
[TBL] [Abstract][Full Text] [Related]
26. Ephrin-B3 ligand promotes glioma invasion through activation of Rac1.
Nakada M; Drake KL; Nakada S; Niska JA; Berens ME
Cancer Res; 2006 Sep; 66(17):8492-500. PubMed ID: 16951161
[TBL] [Abstract][Full Text] [Related]
27. Transcription factor CHF1/Hey2 regulates neointimal formation in vivo and vascular smooth muscle proliferation and migration in vitro.
Sakata Y; Xiang F; Chen Z; Kiriyama Y; Kamei CN; Simon DI; Chin MT
Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2069-74. PubMed ID: 15345511
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of Rac1 GTPase downregulates vascular endothelial growth factor receptor-2 expression by suppressing Sp1-dependent DNA binding in human endothelial cells.
Meissner M; Michailidou D; Stein M; Hrgovic I; Kaufmann R; Gille J
Exp Dermatol; 2009 Oct; 18(10):863-9. PubMed ID: 19469899
[TBL] [Abstract][Full Text] [Related]
29. EphrinA1 inhibits vascular endothelial growth factor-induced intracellular signaling and suppresses retinal neovascularization and blood-retinal barrier breakdown.
Ojima T; Takagi H; Suzuma K; Oh H; Suzuma I; Ohashi H; Watanabe D; Suganami E; Murakami T; Kurimoto M; Honda Y; Yoshimura N
Am J Pathol; 2006 Jan; 168(1):331-9. PubMed ID: 16400034
[TBL] [Abstract][Full Text] [Related]
30. Identification and functional analysis of phosphorylated tyrosine residues within EphA2 receptor tyrosine kinase.
Fang WB; Brantley-Sieders DM; Hwang Y; Ham AJ; Chen J
J Biol Chem; 2008 Jun; 283(23):16017-26. PubMed ID: 18387945
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
Qian F; Engst S; Yamaguchi K; Yu P; Won KA; Mock L; Lou T; Tan J; Li C; Tam D; Lougheed J; Yakes FM; Bentzien F; Xu W; Zaks T; Wooster R; Greshock J; Joly AH
Cancer Res; 2009 Oct; 69(20):8009-16. PubMed ID: 19808973
[TBL] [Abstract][Full Text] [Related]
32. Regulation of EphA2 receptor endocytosis by SHIP2 lipid phosphatase via phosphatidylinositol 3-Kinase-dependent Rac1 activation.
Zhuang G; Hunter S; Hwang Y; Chen J
J Biol Chem; 2007 Jan; 282(4):2683-94. PubMed ID: 17135240
[TBL] [Abstract][Full Text] [Related]
33. The role of the vascular endothelial growth factor-Delta-like 4 ligand/Notch4-ephrin B2 cascade in tumor vessel remodeling and endothelial cell functions.
Hainaud P; Contrerès JO; Villemain A; Liu LX; Plouët J; Tobelem G; Dupuy E
Cancer Res; 2006 Sep; 66(17):8501-10. PubMed ID: 16951162
[TBL] [Abstract][Full Text] [Related]
34. Green tea catechin inhibits ephrin-A1-mediated cell migration and angiogenesis of human umbilical vein endothelial cells.
Tang FY; Chiang EP; Shih CJ
J Nutr Biochem; 2007 Jun; 18(6):391-9. PubMed ID: 17049832
[TBL] [Abstract][Full Text] [Related]
35. TGFbeta1-induced aortic endothelial morphogenesis requires signaling by small GTPases Rac1 and RhoA.
Varon C; Basoni C; Reuzeau E; Moreau V; Kramer IJ; Génot E
Exp Cell Res; 2006 Nov; 312(18):3604-19. PubMed ID: 16978608
[TBL] [Abstract][Full Text] [Related]
36. Ornithine decarboxylase and extracellular polyamines regulate microvascular sprouting and actin cytoskeleton dynamics in endothelial cells.
Kucharzewska P; Welch JE; Svensson KJ; Belting M
Exp Cell Res; 2010 Oct; 316(16):2683-91. PubMed ID: 20594968
[TBL] [Abstract][Full Text] [Related]
37. Receptor EphA2 activation with ephrinA1 suppresses growth of malignant mesothelioma (MM).
Nasreen N; Mohammed KA; Lai Y; Antony VB
Cancer Lett; 2007 Dec; 258(2):215-22. PubMed ID: 17949899
[TBL] [Abstract][Full Text] [Related]
38. ARAP3 is transiently tyrosine phosphorylated in cells attaching to fibronectin and inhibits cell spreading in a RhoGAP-dependent manner.
I ST; Nie Z; Stewart A; Najdovska M; Hall NE; He H; Randazzo PA; Lock P
J Cell Sci; 2004 Dec; 117(Pt 25):6071-84. PubMed ID: 15546919
[TBL] [Abstract][Full Text] [Related]
39. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584.
Qian DZ; Wang X; Kachhap SK; Kato Y; Wei Y; Zhang L; Atadja P; Pili R
Cancer Res; 2004 Sep; 64(18):6626-34. PubMed ID: 15374977
[TBL] [Abstract][Full Text] [Related]
40. The homeobox gene Gax inhibits angiogenesis through inhibition of nuclear factor-kappaB-dependent endothelial cell gene expression.
Patel S; Leal AD; Gorski DH
Cancer Res; 2005 Feb; 65(4):1414-24. PubMed ID: 15735029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
